Cahill Wealth Management, LLC Verona Pharma PLC Transaction History
Cahill Wealth Management, LLC
- $194 Million
- Q3 2024
A detailed history of Cahill Wealth Management, LLC transactions in Verona Pharma PLC stock. As of the latest transaction made, Cahill Wealth Management, LLC holds 7,745 shares of VRNA stock, worth $295,471. This represents 0.11% of its overall portfolio holdings.
Number of Shares
7,745Holding current value
$295,471% of portfolio
0.11%Shares
4 transactions
Others Institutions Holding VRNA
# of Institutions
148Shares Held
66.9MCall Options Held
495KPut Options Held
486K-
Ra Capital Management, L.P. Boston, MA7.63MShares$291 Million1.66% of portfolio
-
Nea Management Company, LLC Timonium, MD5.58MShares$213 Million7.62% of portfolio
-
Deep Track Capital, LP Greenwich, CT4MShares$153 Million1.9% of portfolio
-
Vivo Capital, LLC Palo Alto, CA3.55MShares$135 Million7.58% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.31MShares$126 Million2.82% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $2.33B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...